Fatal Hydrocodone Overdose in a Child: Pharmacogenetics and Drug Interactions

  title={Fatal Hydrocodone Overdose in a Child: Pharmacogenetics and Drug Interactions},
  author={Parvaz Madadi and Doris Hildebrandt and Inna Y. Gong and Ute I. Schwarz and Catherine Ciszkowski and Colin J D Ross and Johanna Sistonen and Bruce C. Carleton and Michael R. Hayden and Albert Edward Lauwers and Gideon Koren},
  pages={e986 - e989}
Fatal opioid toxicity occurred in a developmentally delayed child aged 5 years 9 months who was inadvertently administered high doses of hydrocodone for a respiratory tract infection. [] Key Result The concentration of hydrocodone in postmortem blood was in the range associated with fatality; however, hydromorphone, a major metabolite catalyzed by cytochrome P450 2D6 (CYP2D6), was not detected when using mass spectrometry.

Figures from this paper

Life-threatening adverse events following therapeutic opioid administration in adults: is pharmacogenetic analysis useful?

Pharmacogenetic analysis, together with clinical history, has the potential to provide mechanistic insight into severe respiratory depressive events in patients who receive opioids at therapeutic doses.

Pharmacogenomics of analgesics in anesthesia practice: A current update of literature

There is a fair amount of conflicting data in the above topics, suggesting that there is still a lot of research to be done on these topics, and that pain perception is multifactorial, likely including many common genetic variants.

Potential Cytochrome P450 Drug-Drug Interaction Among Adult and Adolescent Patients Undergoing Tonsillectomy

Nearly 20% of the patients in this cohort were taking a medication that may alter opioid metabolism through induction or inhibition of CYP3A4 or CYP2D6, suggesting interactions that can lead to enhanced toxicity of opioids due to accumulation of active metabolites.

Pharmacogenetics of opiates in clinical practice: the visible tip of the iceberg.

Pharmacogenetic data associated with some opioids frequently encountered in managed care settings are summarized to avoid toxicity.

CYP2D6 genetic polymorphisms and their relevance for poisoning due to amfetamines, opioid analgesics and antidepressants

Either poor or extensive/ultra-rapid CYP2D6 metabolisers may be exposed to toxic effects of amfetamines, opioid analgesics and antidepressants, with differences within the same pharmacological class.

Review of Opioid Pharmacogenetics and Considerations for Pain Management

The influence of polymorphisms in pharmacokinetics genes, as well as pharmacodynamics genes (OPRM1 and COMT) on response to opioids has been a subject of intense research, and the results have been somehow conflicting.

Opioid therapies and cytochrome p450 interactions.

  • J. Gudin
  • Medicine, Biology
    Journal of pain and symptom management
  • 2012

Pharmacokinetics and Pharmacology of Drugs Used in Children

Opioid Pharmacology: Developmental Effects on Opioid Metabolism

  • E. Kopecky
  • Medicine, Biology
    The Clinical journal of pain
  • 2019
Protein binding, tissue solubility, weight, size, blood flow, drug metabolism, and renal function are key determinants of dosing across the different pediatric age cohorts, and each functions to elicit a change in drug exposure and therefore varying clinical effect.

Complex Drug–Drug–Gene–Disease Interactions Involving Cytochromes P450: Systematic Review of Published Case Reports and Clinical Perspectives

The present review illustrates the issue of complex DDIs using systematically searched published case reports of DDIs involving genetic polymorphisms, renal impairment, cirrhosis, and/or inflammation.



Codeine intoxication associated with ultrarapid CYP2D6 metabolism.

CYP2D6 genotyping showed that the patient had three or more functional alleles, a finding consistent with ultrarapid metabolism of codeine, and attribute the toxicity to this genotype in combination with inhibition of CYP3A4 activity by other medications and a transient reduction in renal function.

Pharmacokinetics, drug interactions, and tolerability of valproate.

  • C. DeVane
  • Medicine, Biology
    Psychopharmacology bulletin
  • 2003
This review summarizes valproate's pharmacokinetics, drug interactions, and tolerability as an aid to promote individualized pharmacotherapy and suggests it is generally safe whether administered alone or in combination with other therapies.

Pharmacokinetics, drug interactions, and tolerability of valproate.

This review summarizes valproate's pharmacokinetics, drug interactions, and tolerability as an aid to promote individualized pharmacotherapy and suggests it is generally safe whether administered alone or in combination with other therapies.

CYP2D6 phenotype determines the metabolic conversion of hydrocodone to hydromorphone

The data establish the importance of CYP2D6 in the formation of hydromorphone from hydrocodone and suggest that the activity of this enzyme may limit the abuse liability of hydrocODone.

A Mechanistic Approach to Antiepileptic Drug Interactions

  • G. Anderson
  • Biology, Medicine
    The Annals of pharmacotherapy
  • 1998
By understanding the mechanisms of drug interactions, the pharmacist can play a key role in patient care by anticipating and preventing AED drug interactions.

Death associated with inadvertent hydrocodone overdose in a child with a respiratory tract infection.

  • P. MorrowE. Faris
  • Medicine
    The American journal of forensic medicine and pathology
  • 1987
A 3-year-old child died of the combined effects of a bacterial superinfection and a relative overdose of hydrocodone prescribed for a cough due to a presumed viral respiratory tract infection. This

Postmortem blood ketamine distribution in two fatalities.

Marked differences between heart and femoral blood ketamine concentrations were observed in both of the reported cases, which may be indicative of incomplete distribution prior to death and/or postmortem redistribution of ketamine.

Elevated Morphine Concentrations Determined During Infant Death Investigations: Artifacts of Withdrawal of Care

This is the first report of postmortem morphine concentrations arising directly from administration in conjunction with withdrawal of care in pediatric patients and the implications of this practice on the forensic toxicological interpretation of morphine findings are discussed.

Postmortem oxycodone and hydrocodone blood concentrations.

  • H. Spiller
  • Medicine
    Journal of forensic sciences
  • 2003
A review of autopsy and coroner's reports from 10 counties for the years 2000 and 2001 to locate cases with oxycodone or hydrocodone exposure as a leading cause of death found eighty-eight cases, with oxy codone values associated with a fatality at blood concentrations lower than previously reported.